• Title of article

    Coronary Endothelial Vasomotor Function and Vascular Remodeling in Heart Transplant Recipients Randomized for Tacrolimus or Cyclosporine Immunosuppression Original Research Article

  • Author/Authors

    Paraskevi Petrakopoulou، نويسنده , , Lydia Anthopoulou، نويسنده , , Michael Muscholl، نويسنده , , Volker Klauss، نويسنده , , Wolfgang von Scheidt، نويسنده , , Peter U?berfuhr، نويسنده , , Bruno M. Meiser، نويسنده , , Bruno Reichart، نويسنده , , Michael Weis، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2006
  • Pages
    8
  • From page
    1622
  • To page
    1629
  • Abstract
    Objectives This study aimed to compare changes in coronary endothelial function, systemic endothelin-1 (ET-1) levels, and vascular remodeling in heart transplant recipients randomized to cyclosporin A (CyA) or tacrolimus (Tac) immunosuppression. Background Functional endothelial abnormalities and intimal thickening are sensitive measures of early cardiac allograft vasculopathy (CAV). Methods The randomized, prospective study was performed in two groups of 22 patients, maintained on Tac or CyA and mycophenolate mofetil immunosuppression, 1 and 12 months after heart transplantation. We investigated epicardial luminal diameter, coronary blood flow velocity, and ET-1 plasma levels at 1 and 12 months after transplantation. Structural coronary alterations were determined using intravascular ultrasound. Results Epicardial vasomotor function at baseline and during follow-up was comparable between the groups. Deterioration of microvascular endothelial function during follow-up was significantly enhanced in the CyA versus Tac group (p < 0.05). Circulating ET-1 concentration increased in the CyA group but significantly decreased over time in the Tac group (CyA +17% vs. Tac −25%; p < 0.05). The time-dependent increase in mean intimal area was significantly enhanced in the CyA versus Tac group, whereas the vessel area significantly increased during follow-up in the Tac compared with the CyA group. Conclusions Epicardial endothelial function is comparable between CyA- and Tac-treated patients. Microvascular endothelial function deteriorates more in CyA-treated patients, a finding that correlates with enhanced ET-1 concentration and an increased intimal area during follow-up. The mean vessel area in the Tac group increased over time, indicating positive vascular remodeling. Tac is superior to CyA with respect to microvascular endothelial function, intimal thickening, and vascular remodeling.
  • Keywords
    HLA , cyclosporin A , prostacyclin , endothelin-1 , Tacrolimus , Mycophenolate Mofetil , CAV , IVUS , ET-1 , MPA , TAC , Aza , intravascular ultrasound , PGI2 , CFR , coronary flow velocity reserve , human leukocyte antigen , FP , MMF , cardiac allograft vasculopathy , azathioprine , CyA , Fb , baseline flow velocity , maximal flow velocity , mycophenolic acid
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Serial Year
    2006
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Record number

    460722